EID Parry settles with LycoRed following patent infringement suit

LycoRed has now reached a settlement with Indian firm EID Parry after the carotenoids supplier filed for patent infringement in March last year over its tomato lycopene products and related manufacturing processes.

As part of the terms of the confidential settlement, Parry acknowledged the validity of LycoRed’s asserted patents, which it had previously challenged.

Morris Zelkha, chief executive of LycoRed, said: “[We] invest millions of dollars in researching the efficacy and safety of our proprietary ingredients and continue to differentiate ourselves from other companies in the market by using its proprietary processes to manufacture lycopene and unique compositions​. 

We are strong defenders of our intellectual property, so that LycoRed’s customers can continue to purchase safe and clinically effective Lyc-O-Mato and our other proprietary products, with confidence​.”

The company’s patented Lyc-O-Mato, which was at the heart of the suit, is the only natural tomato lycopene extract in the market with bioactivity, safety, toxicity and efficacy supported by clinical studies, LycoRed said.

Related news

Related products

show more

Food & CPG Packaging Systems: 4 Questions to Ask

Food & CPG Packaging Systems: 4 Questions to Ask

Husky Technologies™ | 06-Dec-2022 | Insight Guide

If you are planning to invest in a new Packaging solution, to help you remain competitive it must meet growing expectations for increased sustainability,...

Follow us

Webinars

Food & Beverage Trailblazers

F&B Trailblazers Podcast